Abstract
Background
To evaluate the diagnostic accuracy of positron emission tomography/computed tomography with 18F-fluorodeoxyglucose (PET/CT), contrast-enhanced CT (CE-CT), and a combined imaging approach (CE-PET/CT) in patients with suspected vascular graft infection (VGI).
Methods
PET/CT and CE-CT were performed prospectively in 23 patients with suspected VGI. Diagnostic accuracy for PET/CT was assessed by using previously suggested cut-off points for maximum standardized uptake values (SUVmax) measured in the vicinity of the graft. Using a new 4-point scale for visual grading, two readers independently assessed the diagnostic accuracy for CE-CT and combined CE-PET/CT. Microbiological culture, obtained after open biopsy or graft explantation, and clinical follow-up of the patients served as the standard of reference.
Results
Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy of PET/CT for the diagnosis of VGI was 100%, 50%, 100%, 72.2%, and 78.3%, using the most favorable SUVmax cut-off ≥ 4.9. Respective values for CE-CT were 100%, 50%, 100%, 72.2%, and 78.3% for reader 1, and 92.3%, 80%, 88.9%, 85.7%, and 86.9% for reader 2; while respective values for combined CE-PET/CT were 100%, 70%, 100%, 81.3%, and 86.9% for reader 1, and 100%, 80%, 100%, 86.7%, and 91.3% for reader 2. Additionally, imaging provided a conclusive clinical diagnosis in patients without graft infection (i.e., other sites of infection): five of ten patients with CE-CT, six of ten patients with PET/CT, and seven of ten patients with combined CE-PET/CT.
Conclusion
The diagnostic accuracy of combined CE-PET/CT in patients with suspected VGI is very high. The combination of the high sensitivity of PET/CT in detecting metabolically active foci in infection, and the high specificity of CE-CT in detecting anatomic alterations, appears to be the reason why combined imaging outperforms stand-alone imaging in diagnosing VGI and may be supportive in future decision-making of difficult cases of suspected VGI.
Clinical Trials.gov Identifier: NCT01821664.
Similar content being viewed by others
References
Hallett JW Jr, Marshall DM, Petterson TM, et al. Graft-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg. 1997;25(2):277–84 discussion 285–286.
Wilson WR, Bower TC, Creager MA, et al. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association. Circulation. 2016;134(20):e412–e60.
Hasse B, Husmann L, Zinkernagel A, Weber R, Lachat M, Mayer D. Vascular graft infections. Swiss Med Wkly. 2013;143:w13754.
Keidar Z, Nitecki S. FDG-PET in prosthetic graft infections. Semin Nucl Med. 2013;43(5):396–402.
Lyons OT, Baguneid M, Barwick TD, et al. Diagnosis of aortic graft infection: a case definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52(6):758–63.
Fukuchi K, Ishida Y, Higashi M, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg. 2005;42(5):919–25.
Keidar Z, Engel A, Hoffman A, Israel O, Nitecki S. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. J Nucl Med. 2007;48(8):1230–6.
Spacek M, Belohlavek O, Votrubova J, Sebesta P, Stadler P. Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging. 2009;36(5):850–8.
Bruggink JL, Glaudemans AW, Saleem BR, et al. Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection. Eur J Vasc Endovasc Surg. 2010;40(3):348–54.
Sah BR, Husmann L, Mayer D, et al. Diagnostic performance of F-FDG-PET/CT in vascular graft infections. Eur J Vasc Endovasc Surg 2015;49(4):455–64.
Tokuda Y, Oshima H, Araki Y, et al. Detection of thoracic aortic prosthetic graft infection with 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Eur J Cardiothorac Surg. 2013;43(6):1183–7.
Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000;27(7):822–32.
Low RN, Wall SD, Jeffrey RB Jr, Sollitto RA, Reilly LM, Tierney LM Jr. Aortoenteric fistula and perigraft infection: evaluation with CT. Radiology. 1990;175(1):157–62.
Bruggink JL, Slart RH, Pol JA, Reijnen MM, Zeebregts CJ. Current role of imaging in diagnosing aortic graft infections. Semin Vasc Surg. 2011;24(4):182–90.
Keidar Z, Pirmisashvili N, Leiderman M, Nitecki S, Israel O. 18F-FDG uptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time. J Nucl Med. 2014;55(3):392–5.
Husmann L, Hasse B. PET-CT in vascular graft infections. Zentralbl Chir. 2017;142(5):502–5.
Pfannenberg AC, Aschoff P, Brechtel K, et al. Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging. Br J Radiol. 2007;80(954):437–45.
Saleem BR, Berger P, Vaartjes I, et al. Modest utility of quantitative measures in F-fluorodeoxyglucose positron emission tomography scanning for the diagnosis of aortic prosthetic graft infection. J Vasc Surg 2014;61(4):965–71.
Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–68.
Pizzi MN, Roque A, Fernandez-Hidalgo N, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and Intracardiac devices with 18F-Fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation. 2015;132(12):1113–26.
Kagna O, Kurash M, Ghanem-Zouabi N, Keidar Z, Israel O. Does antibiotic treatment affect the diagnostic accuracy of FDG PET/CT studies in patients with suspected infectious processes? J Nucl Med. 2017;58(11):1827–1830.
Acknowledgements
We are grateful to our patients for their commitment, and thank B. Ruehe, C. Rüegg, A. Wolfensberger, U. Matt, M. Kälin, M. Greiner and R. Pop for excellent patient care. We also thank C. Müller and S. Bürgin, study nurses and C. Vögtli for administrative assistance.
The members of the Vascular Graft Cohort Study (VASGRA) are (in alphabetical order): A. Anagnostopoulos, N. Eberhard, B. Hasse (Principal investigator), L. Husmann, B. Ledergerber, M. Lachat, D. Mayer, Z. Rancic, A. Scherrer, A. Weber, R. Weber, R. Zbinden, A. Zinkernagel.
Funding
This study was financed within the framework of the Vascular Graft Cohort Study (VASGRA), supported by Swiss National Science Foundation (SNF) grant #32473B_163132/1, a SNF protected-research-time grant for clinicians #32473B_163132/2, the Vontobel Foundation, and the Rozalia Foundation (all to BH). AA is supported by the academic career program “Filling the gap” of the Medical Faculty of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Consortia
Contributions
BH and LH designed the study. BL analyzed the data. LH and BH wrote the first draft, and LH, BL, AA, and BH wrote the final version of the manuscript. All investigators contributed to collection and interpretation of the data, reviewed drafts of the manuscript, and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board approved the study, and we obtained written informed consent from all participants (KEK-ZH-Nr. 2012–0583).
Rights and permissions
About this article
Cite this article
Husmann, L., Huellner, M.W., Ledergerber, B. et al. Comparing diagnostic accuracy of 18F-FDG-PET/CT, contrast enhanced CT and combined imaging in patients with suspected vascular graft infections. Eur J Nucl Med Mol Imaging 46, 1359–1368 (2019). https://doi.org/10.1007/s00259-018-4205-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-018-4205-y